1 / 30

Parental trials in CR

Parental trials in CR. Ing. Miroslav Stuchl ik Parent Project Czech R epublic. Parent Project. Founded 2001 Registry 2004 Protandim 2007 Haelan 2008 UDCA ?. Registry. Part of Treat -NMD 202 patients from Czech and Slovak Republic http://dystrofie.registry.cz/. Protandim.

viviank
Télécharger la présentation

Parental trials in CR

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Parental trials in CR Ing. Miroslav Stuchlik Parent Project Czech Republic

  2. Parent Project • Founded 2001 • Registry 2004 • Protandim 2007 • Haelan 2008 • UDCA ?

  3. Registry • Part of Treat-NMD • 202 patients from Czech and Slovak Republic • http://dystrofie.registry.cz/

  4. Protandim Trial construction • 17 boys: 15 DMD, 1 BMD, 1 intermediate form • Dosage: ½ pill below 32kg, 1 pill above 32kg • Duration: 90 days • Evaluated • Parental observation • CK, ALT, AST, LD • Spirometry • Osteopontin

  5. Protandim Parental observation • Walking (endurance) • evaluated only at ambulant • improvement in 4 from 6 • No improvement: 1 BMD, 1 another healthy issue • Stairs (force) • improvement in 4 from 6 • Later onset then in walking

  6. Protandim Parental observation • Hands strength • Improvement 5x – all wheelchair bounded • “Again able drink without help” • Energy • Improvement 13x

  7. Protandim Parental observation • Learning, speaking • Improvement 8x • Speaking, memory, singing, better results at school • Inflammation • Improvement 9x • Always only slight improvement

  8. Protandim Parental observation • Better swimming • Better sleeping • Reduced pain in calves • Not any improvement observed at BMD boy

  9. Protandim • CK • E: strong bronchitis at the end of trial • A, K, O – still ambulant

  10. Protandim

  11. Protandim

  12. Protandim

  13. Protandim

  14. Protandim • Spirometry • Only at some wheelchair bounded boys • Results controversial • Probably too difficult for boys with DMD

  15. Protandim • Osteopontin (OPN,SPP1,Eta-1) • Multifunctional protein, plays role in • Mineralisation of tissues • Regulation of inflammation • Vascular diseases • Imunne system • Healing process • Most upregulated gene and protein in mdx mice • Contributing factor in the clinical progression of DMD • Overexpression of Nrf2 significantly decreases mRNA expression of OPN • Protandim activates Nrf2 and consequently ARE

  16. Protandim • Overexpression leads to OPN polymerisation • Polymerized OPN is supposed to have pathophysiological function

  17. Protandim

  18. Haelan 951 Trial construction • 18 boys • Dosage: • 6 weeks: 120ml/day • 8 weeks: 60ml/day • Evaluated • Parental observation • CK, ALT, AST, LD, TNF-α • Results recieved only from 9 boys

  19. Haelan 951 Parental observation • Walking (endurance) • No improvement reported • Stairs (force) • No improvement • Hands strength • No improvement • 1x decline

  20. Haelan 951 Parental observation • Energy • Improvement 4x • Learning, speaking • Better concentration 2x • Inflammation • No improvement

  21. Haelan 951 Parental observation • Improved immunity • Faster regeneration after illnesses • Better sleeping • Better respiration

  22. Haelan 951

  23. Haelan 951

  24. Haelan 951

  25. Haelan 951

  26. Haelan 951

  27. Ursodeoxycholic acid (UDCA) • Non-corticoidal steroids • Anti-inflammatory effect • Upregulate utrophin • Stimulate antioxidative system • Amplifies action of Protandim at low concentration • Used for other diagnosis, serious side effects not known

  28. Ursodeoxycholic acid (UDCA)

  29. Ursodeoxycholic acid (UDCA)

More Related